Cargando…

Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein

Previous studies of human traumatic brain injury (TBI) have shown diffuse axonal injury as varicosities or spheroids in white matter (WM) bundles when using immunoperoxidase‐ABC staining with 22C11, a mouse monoclonal antibody against amyloid precursor protein (APP). These findings have been interpr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Guoxiang, Metheny, Hannah, Hood, Kaitlin, Jean, Ian, Farrugia, Anthony M., Johnson, Brian N., Tummala, Shanti R., Cohen, Noam A., Cohen, Akiva S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580020/
https://www.ncbi.nlm.nih.gov/pubmed/37156643
http://dx.doi.org/10.1111/bpa.13163
_version_ 1785121858825224192
author Xiong, Guoxiang
Metheny, Hannah
Hood, Kaitlin
Jean, Ian
Farrugia, Anthony M.
Johnson, Brian N.
Tummala, Shanti R.
Cohen, Noam A.
Cohen, Akiva S.
author_facet Xiong, Guoxiang
Metheny, Hannah
Hood, Kaitlin
Jean, Ian
Farrugia, Anthony M.
Johnson, Brian N.
Tummala, Shanti R.
Cohen, Noam A.
Cohen, Akiva S.
author_sort Xiong, Guoxiang
collection PubMed
description Previous studies of human traumatic brain injury (TBI) have shown diffuse axonal injury as varicosities or spheroids in white matter (WM) bundles when using immunoperoxidase‐ABC staining with 22C11, a mouse monoclonal antibody against amyloid precursor protein (APP). These findings have been interpreted as TBI‐induced axonal pathology. In a mouse model of TBI however, when we used immunofluorescent staining with 22C11, as opposed to immunoperoxidase staining, we did not observe varicosities or spheroids. To explore this discrepancy, we performed immunofluorescent staining with Y188, an APP knockout‐validated rabbit monoclonal that shows baseline immunoreactivity in neurons and oligodendrocytes of non‐injured mice, with some arranged‐like varicosities. In gray matter after injury, Y188 intensely stained axonal blebs. In WM, we encountered large patches of heavily stained puncta, heterogeneous in size. Scattered axonal blebs were also identified among these Y188‐stained puncta. To assess the neuronal origin of Y188 staining after TBI we made use of transgenic mice with fluorescently labeled neurons and axons. A close correlation was observed between Y188‐stained axonal blebs and fluorescently labeled neuronal cell bodies/axons. By contrast, no correlation was observed between Y188‐stained puncta and fluorescent axons in WM, suggesting that these puncta in WM did not originate from axons, and casting further doubt on the nature of previous reports with 22C11. As such, we strongly recommend Y188 as a biomarker for detecting damaged neurons and axons after TBI. With Y188, stained axonal blebs likely represent acute axonal truncations that may lead to death of the parent neurons. Y188‐stained puncta in WM may indicate damaged oligodendrocytes, whose death and clearance can result in secondary demyelination and Wallerian degeneration of axons. We also provide evidence suggesting that 22C11‐stained varicosities or spheroids previously reported in TBI patients might be showing damaged oligodendrocytes, due to a cross‐reaction between the ABC kit and upregulated endogenous biotin.
format Online
Article
Text
id pubmed-10580020
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105800202023-10-18 Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein Xiong, Guoxiang Metheny, Hannah Hood, Kaitlin Jean, Ian Farrugia, Anthony M. Johnson, Brian N. Tummala, Shanti R. Cohen, Noam A. Cohen, Akiva S. Brain Pathol Research Articles Previous studies of human traumatic brain injury (TBI) have shown diffuse axonal injury as varicosities or spheroids in white matter (WM) bundles when using immunoperoxidase‐ABC staining with 22C11, a mouse monoclonal antibody against amyloid precursor protein (APP). These findings have been interpreted as TBI‐induced axonal pathology. In a mouse model of TBI however, when we used immunofluorescent staining with 22C11, as opposed to immunoperoxidase staining, we did not observe varicosities or spheroids. To explore this discrepancy, we performed immunofluorescent staining with Y188, an APP knockout‐validated rabbit monoclonal that shows baseline immunoreactivity in neurons and oligodendrocytes of non‐injured mice, with some arranged‐like varicosities. In gray matter after injury, Y188 intensely stained axonal blebs. In WM, we encountered large patches of heavily stained puncta, heterogeneous in size. Scattered axonal blebs were also identified among these Y188‐stained puncta. To assess the neuronal origin of Y188 staining after TBI we made use of transgenic mice with fluorescently labeled neurons and axons. A close correlation was observed between Y188‐stained axonal blebs and fluorescently labeled neuronal cell bodies/axons. By contrast, no correlation was observed between Y188‐stained puncta and fluorescent axons in WM, suggesting that these puncta in WM did not originate from axons, and casting further doubt on the nature of previous reports with 22C11. As such, we strongly recommend Y188 as a biomarker for detecting damaged neurons and axons after TBI. With Y188, stained axonal blebs likely represent acute axonal truncations that may lead to death of the parent neurons. Y188‐stained puncta in WM may indicate damaged oligodendrocytes, whose death and clearance can result in secondary demyelination and Wallerian degeneration of axons. We also provide evidence suggesting that 22C11‐stained varicosities or spheroids previously reported in TBI patients might be showing damaged oligodendrocytes, due to a cross‐reaction between the ABC kit and upregulated endogenous biotin. John Wiley and Sons Inc. 2023-05-08 /pmc/articles/PMC10580020/ /pubmed/37156643 http://dx.doi.org/10.1111/bpa.13163 Text en © 2023 Children's Hospital of Philadelphia. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Xiong, Guoxiang
Metheny, Hannah
Hood, Kaitlin
Jean, Ian
Farrugia, Anthony M.
Johnson, Brian N.
Tummala, Shanti R.
Cohen, Noam A.
Cohen, Akiva S.
Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein
title Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein
title_full Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein
title_fullStr Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein
title_full_unstemmed Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein
title_short Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein
title_sort detection and verification of neurodegeneration after traumatic brain injury in the mouse: immunohistochemical staining for amyloid precursor protein
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580020/
https://www.ncbi.nlm.nih.gov/pubmed/37156643
http://dx.doi.org/10.1111/bpa.13163
work_keys_str_mv AT xiongguoxiang detectionandverificationofneurodegenerationaftertraumaticbraininjuryinthemouseimmunohistochemicalstainingforamyloidprecursorprotein
AT methenyhannah detectionandverificationofneurodegenerationaftertraumaticbraininjuryinthemouseimmunohistochemicalstainingforamyloidprecursorprotein
AT hoodkaitlin detectionandverificationofneurodegenerationaftertraumaticbraininjuryinthemouseimmunohistochemicalstainingforamyloidprecursorprotein
AT jeanian detectionandverificationofneurodegenerationaftertraumaticbraininjuryinthemouseimmunohistochemicalstainingforamyloidprecursorprotein
AT farrugiaanthonym detectionandverificationofneurodegenerationaftertraumaticbraininjuryinthemouseimmunohistochemicalstainingforamyloidprecursorprotein
AT johnsonbriann detectionandverificationofneurodegenerationaftertraumaticbraininjuryinthemouseimmunohistochemicalstainingforamyloidprecursorprotein
AT tummalashantir detectionandverificationofneurodegenerationaftertraumaticbraininjuryinthemouseimmunohistochemicalstainingforamyloidprecursorprotein
AT cohennoama detectionandverificationofneurodegenerationaftertraumaticbraininjuryinthemouseimmunohistochemicalstainingforamyloidprecursorprotein
AT cohenakivas detectionandverificationofneurodegenerationaftertraumaticbraininjuryinthemouseimmunohistochemicalstainingforamyloidprecursorprotein